17 research outputs found
Recommended from our members
The impact of despecialisation and redeployment on surgical training in the midst of the COVID-19 pandemic.
Recommended from our members
New drug, new problem: do hip fracture patients taking NOACs experience delayed surgery, longer hospital stay, or poorer outcomes?
INTRODUCTION: Neck of femur fractures are common in the comorbid, often anticoagulated, elderly. Non-vitamin K antagonist oral anticoagulants (NOACs) may affect patient outcomes. We aimed to evaluate whether hip fracture patients admitted on warfarin or NOAC therapy were at risk of operative delay, prolonged length of stay, or increased mortality. METHODS: We collected data for 845 patients admitted to our centre between October 2014 and December 2016. Multivariable linear regression analysis was performed to test the association between warfarin and NOAC therapy on time to surgery and length of stay. Variables in the regression model were age, sex, admission AMTS, pre-fracture mobility, ASA score, fracture type, and operation type. Fisher's exact test was used to evaluate whether warfarin or NOAC therapy delayed surgery beyond 36 or 48 hours, or decreased 30-day, 6-month, or 12-month survival. RESULTS: Time to surgery was delayed in anticoagulated patients (p = 0.028). NOAC therapy was independently associated with increased time to surgery beyond 36 hours (p = 0.001), although not beyond 48 hours (p = 0.355), whereas warfarin therapy was not associated with either. Anticoagulation did not increase length of stay (p = 0.331). Warfarin therapy significantly reduced 30-day survival (p = 0.007), but NOAC therapy did not (p = 0.244). Neither warfarin nor NOAC therapy affected further survival. CONCLUSIONS: NOAC therapy delays time to surgery beyond the NHS England 'Best Practice Tariff' in hip fracture patients. We aim to prospectively investigate long-term outcomes. Without a NOAC antidote, policy must change to ensure time-appropriate surgery for patients on NOACs. Preoperative involvement of the haematology team is essential.non
Combination of acellular dermal matrix with a de-epithelialised dermal flap during skin-reducing mastectomy and immediate breast reconstruction
INTRODUCTION: Patients with large ptotic breasts undergoing immediate implant-based reconstruction often require skin-reducing
mastectomy to optimise the aesthetic outcome. However, healing complications, especially at the resulting inverted T-junction,
leading to wound dehiscence, infection, skin necrosis, implant exposure and failed reconstruction have been widely
reported. We present an innovative approach for immediate implant-based reconstruction combining porcine- or bovine-derived
acellular dermal matrices with a de-epithelialised dermal sling to protect and support the implant, while improving clinical outcomes
in this challenging group of patients.
MATERIALS AND METHODS: Demographic, tumour and surgical data were reviewed for patients undergoing Wise pattern (T-scar)
skin-reducing mastectomies with immediate implant-based reconstruction combining porcine- or bovine-derived acellular dermal
matrices with a de-epithelialised dermal sling.
RESULTS: This technique was successfully employed to reconstruct five large pendulous breasts in four breast cancer patients
with a median age of 50.5 years (range 34–61 years) who were not suitable for, or had declined, flap-based reconstruction.
The acellular dermal matrices used were SurgiMend®, StratticeTM and Braxon® and the expandable implants were placed in
the sub-pectoral (n = 3) and pre-pectoral (n = 1) planes. The technical steps and clinical outcomes are presented. One patient
experienced T-junction breakdown overlying the de-epithelialised dermis without implant loss.
CONCLUSION: The combination of an acellular dermal matrix and a dermal sling provides a double-layer ‘water-proofing’ and
support for the implants inferiorly, avoiding T-junction breakdown complications, since any dehiscence is on to well-vascularised
dermis. Furthermore, the acellular dermal matrix stabilises the implant in the large mastectomy cavity (pocket control).
This approach provides a viable option which facilitates mastectomy and immediate implant reconstruction in large-breasted
patients
Trends in post-mastectomy breast reconstruction types at a breast cancer tertiary referral centre before and after introduction of acellular dermal matrices
Background:
Reconstructive breast surgery has continued to evolve over the last decade with a key change being the adoption of acellular dermal matrices (ADMs) as an adjunct for implant-based procedures. This retrospective observational study assesses the effect of ADMs on post-mastectomy reconstructive practice performed in a single institution.
Methods:
We conducted a review of all patients undergoing breast reconstruction at a University Teaching Hospital for an 18-month period before and after adopting ADMs. Demographic, procedural and complication data for these two cohorts were compared (χ2 and Student's t-tests).
Results:
A total of 264 women (336 breasts), mean age 47.5 years, were identified: 137 before and 127 after the introduction of ADM. Implant-only reconstructions increased from 16% to 52% following the adoption of ADM (p < 0.01), whereas the proportion of both latissimus dorsi and deep inferior epigastric perforator flap reconstructions decreased significantly (31%–11% and 49%–34%, respectively, p < 0.01). The rate of early complications for the implant-only procedures was not significantly different with or without ADM (26% versus 20%, respectively, p = 0.44), despite there being no difference in the rate of adjuvant radiotherapy (22% versus 35%, respectively, p = 0.30).
Conclusions:
This study showed that since ADM introduction to our centre, more breast reconstructions have been of the implant-only type with consequent reductions in the more complex and expensive autologous techniques. Implant-only procedures that incorporated ADM use had similar complication rates to those that did not